Standard InChI: InChI=1S/C19H19NO4/c1-20-8-7-12-9-13(5-6-15(12)20)18(21)14-10-16(22-2)19(24-4)17(11-14)23-3/h5-11H,1-4H3
Standard InChI Key: ZACNDXXBCBNGMV-UHFFFAOYSA-N
Associated Targets(Human)
KB 17409 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NCI-H460 60772 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HT-29 80576 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
TSGH 45 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MKN-45 2102 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Tubulin 5180 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
CCRF-CEM 65223 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MOLT-3 638 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Bel-7402 4577 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DU-145 51482 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
PC-3 62116 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HeLa 62764 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A549 127892 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HL-60 67320 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 325.36
Molecular Weight (Monoisotopic): 325.1314
AlogP: 3.44
#Rotatable Bonds: 5
Polar Surface Area: 49.69
Molecular Species: NEUTRAL
HBA: 5
HBD: 0
#RO5 Violations: 0
HBA (Lipinski): 5
HBD (Lipinski): 0
#RO5 Violations (Lipinski): 0
CX Acidic pKa:
CX Basic pKa:
CX LogP: 3.28
CX LogD: 3.28
Aromatic Rings: 3
Heavy Atoms: 24
QED Weighted: 0.67
Np Likeness Score: -0.28
References
1.Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY.. (2007) 4- and 5-aroylindoles as novel classes of potent antitubulin agents., 50 (18):[PMID:17685504][10.1021/jm070557q]
2.Hu L, Jiang JD, Qu J, Li Y, Jin J, Li ZR, Boykin DW.. (2007) Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships., 17 (13):[PMID:17482458][10.1016/j.bmcl.2007.04.048]
3.Alvarez C, Alvarez R, Corchete P, López JL, Pérez-Melero C, Peláez R, Medarde M.. (2008) Diarylmethyloxime and hydrazone derivatives with 5-indolyl moieties as potent inhibitors of tubulin polymerization., 16 (11):[PMID:18502133][10.1016/j.bmc.2008.04.054]
4.Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M.. (2010) Exploring the effect of 2,3,4-trimethoxy-phenyl moiety as a component of indolephenstatins., 45 (2):[PMID:19939521][10.1016/j.ejmech.2009.10.047]
5.Alvarez R, Alvarez C, Mollinedo F, Sierra BG, Medarde M, Peláez R.. (2009) Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds., 17 (17):[PMID:19647439][10.1016/j.bmc.2009.07.012]
6.Álvarez R, Puebla P, Díaz JF, Bento AC, García-Navas R, de la Iglesia-Vicente J, Mollinedo F, Andreu JM, Medarde M, Peláez R.. (2013) Endowing indole-based tubulin inhibitors with an anchor for derivatization: highly potent 3-substituted indolephenstatins and indoleisocombretastatins., 56 (7):[PMID:23470139][10.1021/jm3015603]